Loading…
S100B immunization triggers NFκB and complement activation in an autoimmune glaucoma model
In glaucoma, latest studies revealed an involvement of the complement system with and without an elevated intraocular pressure. In the experimental autoimmune glaucoma model, immunization with antigens, such as S100B, lead to retinal ganglion cell (RGC) loss and optic nerve degeneration after 28 day...
Saved in:
Published in: | Scientific reports 2018-06, Vol.8 (1), p.9821-12, Article 9821 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3896-ad7f619e9346cdcd23a62372351e59070f0bf8f909e3d738a61d97a4bc4400b23 |
---|---|
cites | cdi_FETCH-LOGICAL-c3896-ad7f619e9346cdcd23a62372351e59070f0bf8f909e3d738a61d97a4bc4400b23 |
container_end_page | 12 |
container_issue | 1 |
container_start_page | 9821 |
container_title | Scientific reports |
container_volume | 8 |
creator | Reinehr, Sabrina Reinhard, Jacqueline Gandej, Marcel Gottschalk, Ivo Stute, Gesa Faissner, Andreas Dick, H. Burkhard Joachim, Stephanie C. |
description | In glaucoma, latest studies revealed an involvement of the complement system with and without an elevated intraocular pressure. In the experimental autoimmune glaucoma model, immunization with antigens, such as S100B, lead to retinal ganglion cell (RGC) loss and optic nerve degeneration after 28 days. Here, we investigated the timeline of progression of the complement system, toll-like-receptor 4 (TLR4), and the transcription factor nucleus factor-kappa B (NFκB). Therefore, rats were immunized with S100B protein (S100) and analyzed at 3, 7, and 14 days. RGC numbers were comparable at all points in time, whereas a destruction of S100 optic nerves was noted at 14 days. A significant increase of mannose binding lectin (MBL) was observed in S100 retinas at 3 days. Subsequently, significantly more MBL
+
cells were seen in S100 optic nerves at 7 and 14 days. Accordingly, C3 was upregulated in S100 retinas at 14 days. An increase of interleukin-1 beta was noted in S100 aqueous humor samples at 7 days. In this study, activation of complement system via the lectin pathway was obvious. However, no TLR4 alterations were noted in S100 retinas and optic nerves. Interestingly, a significant NFκB increase was observed in S100 retinas at 7 and 14 days. We assume that NFκB activation might be triggered via MBL leading to glaucomatous damage. |
doi_str_mv | 10.1038/s41598-018-28183-6 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6026137</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2061817583</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3896-ad7f619e9346cdcd23a62372351e59070f0bf8f909e3d738a61d97a4bc4400b23</originalsourceid><addsrcrecordid>eNp9kc9O5SAYxYnRqFFfwIUhceOmzge0FDYmo9FxEqMLdeWCcCm9Ylq4A62JPto8xDzTcK3_ZhaygeT8zuH7chDaJXBIgIlvqSSVFAUQUVBBBCv4CtqkUFYFZZSufnpvoJ2UHiCfisqSyHW0QaWsZMnoJrq7JgDH2PX96N2zHlzweIhuPrcx4cuzP7-PsfYNNqFfdLa3fsDaDO5xAp3PItbjEF78Fs87PWZU4z40tttGa63ukt15vbfQ7dnpzcl5cXH14-fJ94vCMCF5oZu65URayUpuGtNQpjllNWUVsZWEGlqYtaKVIC1raiY0J42sdTkzZQkwo2wLHU25i3HW28bkKaPu1CK6XscnFbRT_yre3at5eFQcKCeszgEHrwEx_BptGlTvkrFdp70NY1IUOBWsBs4yuv8f-hDG6PN6S4oIUldiSdGJMjGkFG37PgwBtaxPTfWpXJ96qU_xbNr7vMa75a2sDLAJSFnyuaGPv7-I_QuVoKYT</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2061817583</pqid></control><display><type>article</type><title>S100B immunization triggers NFκB and complement activation in an autoimmune glaucoma model</title><source>Publicly Available Content Database</source><source>Full-Text Journals in Chemistry (Open access)</source><source>PubMed Central</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Reinehr, Sabrina ; Reinhard, Jacqueline ; Gandej, Marcel ; Gottschalk, Ivo ; Stute, Gesa ; Faissner, Andreas ; Dick, H. Burkhard ; Joachim, Stephanie C.</creator><creatorcontrib>Reinehr, Sabrina ; Reinhard, Jacqueline ; Gandej, Marcel ; Gottschalk, Ivo ; Stute, Gesa ; Faissner, Andreas ; Dick, H. Burkhard ; Joachim, Stephanie C.</creatorcontrib><description>In glaucoma, latest studies revealed an involvement of the complement system with and without an elevated intraocular pressure. In the experimental autoimmune glaucoma model, immunization with antigens, such as S100B, lead to retinal ganglion cell (RGC) loss and optic nerve degeneration after 28 days. Here, we investigated the timeline of progression of the complement system, toll-like-receptor 4 (TLR4), and the transcription factor nucleus factor-kappa B (NFκB). Therefore, rats were immunized with S100B protein (S100) and analyzed at 3, 7, and 14 days. RGC numbers were comparable at all points in time, whereas a destruction of S100 optic nerves was noted at 14 days. A significant increase of mannose binding lectin (MBL) was observed in S100 retinas at 3 days. Subsequently, significantly more MBL
+
cells were seen in S100 optic nerves at 7 and 14 days. Accordingly, C3 was upregulated in S100 retinas at 14 days. An increase of interleukin-1 beta was noted in S100 aqueous humor samples at 7 days. In this study, activation of complement system via the lectin pathway was obvious. However, no TLR4 alterations were noted in S100 retinas and optic nerves. Interestingly, a significant NFκB increase was observed in S100 retinas at 7 and 14 days. We assume that NFκB activation might be triggered via MBL leading to glaucomatous damage.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-018-28183-6</identifier><identifier>PMID: 29959432</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13/51 ; 14/63 ; 38/77 ; 692/420 ; 692/699 ; Antigens ; Complement activation ; Complement component C3 ; Degeneration ; Glaucoma ; Humanities and Social Sciences ; Immunization ; Interleukin 1 ; Mannose ; multidisciplinary ; NF-κB protein ; Nuclei ; Optic nerve ; Retina ; Retinal ganglion cells ; S100b protein ; Science ; Science (multidisciplinary) ; TLR4 protein ; Toll-like receptors</subject><ispartof>Scientific reports, 2018-06, Vol.8 (1), p.9821-12, Article 9821</ispartof><rights>The Author(s) 2018</rights><rights>2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3896-ad7f619e9346cdcd23a62372351e59070f0bf8f909e3d738a61d97a4bc4400b23</citedby><cites>FETCH-LOGICAL-c3896-ad7f619e9346cdcd23a62372351e59070f0bf8f909e3d738a61d97a4bc4400b23</cites><orcidid>0000-0001-7056-0829 ; 0000-0002-2211-8259</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2061817583/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2061817583?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29959432$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reinehr, Sabrina</creatorcontrib><creatorcontrib>Reinhard, Jacqueline</creatorcontrib><creatorcontrib>Gandej, Marcel</creatorcontrib><creatorcontrib>Gottschalk, Ivo</creatorcontrib><creatorcontrib>Stute, Gesa</creatorcontrib><creatorcontrib>Faissner, Andreas</creatorcontrib><creatorcontrib>Dick, H. Burkhard</creatorcontrib><creatorcontrib>Joachim, Stephanie C.</creatorcontrib><title>S100B immunization triggers NFκB and complement activation in an autoimmune glaucoma model</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>In glaucoma, latest studies revealed an involvement of the complement system with and without an elevated intraocular pressure. In the experimental autoimmune glaucoma model, immunization with antigens, such as S100B, lead to retinal ganglion cell (RGC) loss and optic nerve degeneration after 28 days. Here, we investigated the timeline of progression of the complement system, toll-like-receptor 4 (TLR4), and the transcription factor nucleus factor-kappa B (NFκB). Therefore, rats were immunized with S100B protein (S100) and analyzed at 3, 7, and 14 days. RGC numbers were comparable at all points in time, whereas a destruction of S100 optic nerves was noted at 14 days. A significant increase of mannose binding lectin (MBL) was observed in S100 retinas at 3 days. Subsequently, significantly more MBL
+
cells were seen in S100 optic nerves at 7 and 14 days. Accordingly, C3 was upregulated in S100 retinas at 14 days. An increase of interleukin-1 beta was noted in S100 aqueous humor samples at 7 days. In this study, activation of complement system via the lectin pathway was obvious. However, no TLR4 alterations were noted in S100 retinas and optic nerves. Interestingly, a significant NFκB increase was observed in S100 retinas at 7 and 14 days. We assume that NFκB activation might be triggered via MBL leading to glaucomatous damage.</description><subject>13/51</subject><subject>14/63</subject><subject>38/77</subject><subject>692/420</subject><subject>692/699</subject><subject>Antigens</subject><subject>Complement activation</subject><subject>Complement component C3</subject><subject>Degeneration</subject><subject>Glaucoma</subject><subject>Humanities and Social Sciences</subject><subject>Immunization</subject><subject>Interleukin 1</subject><subject>Mannose</subject><subject>multidisciplinary</subject><subject>NF-κB protein</subject><subject>Nuclei</subject><subject>Optic nerve</subject><subject>Retina</subject><subject>Retinal ganglion cells</subject><subject>S100b protein</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>TLR4 protein</subject><subject>Toll-like receptors</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp9kc9O5SAYxYnRqFFfwIUhceOmzge0FDYmo9FxEqMLdeWCcCm9Ylq4A62JPto8xDzTcK3_ZhaygeT8zuH7chDaJXBIgIlvqSSVFAUQUVBBBCv4CtqkUFYFZZSufnpvoJ2UHiCfisqSyHW0QaWsZMnoJrq7JgDH2PX96N2zHlzweIhuPrcx4cuzP7-PsfYNNqFfdLa3fsDaDO5xAp3PItbjEF78Fs87PWZU4z40tttGa63ukt15vbfQ7dnpzcl5cXH14-fJ94vCMCF5oZu65URayUpuGtNQpjllNWUVsZWEGlqYtaKVIC1raiY0J42sdTkzZQkwo2wLHU25i3HW28bkKaPu1CK6XscnFbRT_yre3at5eFQcKCeszgEHrwEx_BptGlTvkrFdp70NY1IUOBWsBs4yuv8f-hDG6PN6S4oIUldiSdGJMjGkFG37PgwBtaxPTfWpXJ96qU_xbNr7vMa75a2sDLAJSFnyuaGPv7-I_QuVoKYT</recordid><startdate>20180629</startdate><enddate>20180629</enddate><creator>Reinehr, Sabrina</creator><creator>Reinhard, Jacqueline</creator><creator>Gandej, Marcel</creator><creator>Gottschalk, Ivo</creator><creator>Stute, Gesa</creator><creator>Faissner, Andreas</creator><creator>Dick, H. Burkhard</creator><creator>Joachim, Stephanie C.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7056-0829</orcidid><orcidid>https://orcid.org/0000-0002-2211-8259</orcidid></search><sort><creationdate>20180629</creationdate><title>S100B immunization triggers NFκB and complement activation in an autoimmune glaucoma model</title><author>Reinehr, Sabrina ; Reinhard, Jacqueline ; Gandej, Marcel ; Gottschalk, Ivo ; Stute, Gesa ; Faissner, Andreas ; Dick, H. Burkhard ; Joachim, Stephanie C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3896-ad7f619e9346cdcd23a62372351e59070f0bf8f909e3d738a61d97a4bc4400b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>13/51</topic><topic>14/63</topic><topic>38/77</topic><topic>692/420</topic><topic>692/699</topic><topic>Antigens</topic><topic>Complement activation</topic><topic>Complement component C3</topic><topic>Degeneration</topic><topic>Glaucoma</topic><topic>Humanities and Social Sciences</topic><topic>Immunization</topic><topic>Interleukin 1</topic><topic>Mannose</topic><topic>multidisciplinary</topic><topic>NF-κB protein</topic><topic>Nuclei</topic><topic>Optic nerve</topic><topic>Retina</topic><topic>Retinal ganglion cells</topic><topic>S100b protein</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>TLR4 protein</topic><topic>Toll-like receptors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reinehr, Sabrina</creatorcontrib><creatorcontrib>Reinhard, Jacqueline</creatorcontrib><creatorcontrib>Gandej, Marcel</creatorcontrib><creatorcontrib>Gottschalk, Ivo</creatorcontrib><creatorcontrib>Stute, Gesa</creatorcontrib><creatorcontrib>Faissner, Andreas</creatorcontrib><creatorcontrib>Dick, H. Burkhard</creatorcontrib><creatorcontrib>Joachim, Stephanie C.</creatorcontrib><collection>SpringerOpen</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reinehr, Sabrina</au><au>Reinhard, Jacqueline</au><au>Gandej, Marcel</au><au>Gottschalk, Ivo</au><au>Stute, Gesa</au><au>Faissner, Andreas</au><au>Dick, H. Burkhard</au><au>Joachim, Stephanie C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>S100B immunization triggers NFκB and complement activation in an autoimmune glaucoma model</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2018-06-29</date><risdate>2018</risdate><volume>8</volume><issue>1</issue><spage>9821</spage><epage>12</epage><pages>9821-12</pages><artnum>9821</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>In glaucoma, latest studies revealed an involvement of the complement system with and without an elevated intraocular pressure. In the experimental autoimmune glaucoma model, immunization with antigens, such as S100B, lead to retinal ganglion cell (RGC) loss and optic nerve degeneration after 28 days. Here, we investigated the timeline of progression of the complement system, toll-like-receptor 4 (TLR4), and the transcription factor nucleus factor-kappa B (NFκB). Therefore, rats were immunized with S100B protein (S100) and analyzed at 3, 7, and 14 days. RGC numbers were comparable at all points in time, whereas a destruction of S100 optic nerves was noted at 14 days. A significant increase of mannose binding lectin (MBL) was observed in S100 retinas at 3 days. Subsequently, significantly more MBL
+
cells were seen in S100 optic nerves at 7 and 14 days. Accordingly, C3 was upregulated in S100 retinas at 14 days. An increase of interleukin-1 beta was noted in S100 aqueous humor samples at 7 days. In this study, activation of complement system via the lectin pathway was obvious. However, no TLR4 alterations were noted in S100 retinas and optic nerves. Interestingly, a significant NFκB increase was observed in S100 retinas at 7 and 14 days. We assume that NFκB activation might be triggered via MBL leading to glaucomatous damage.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>29959432</pmid><doi>10.1038/s41598-018-28183-6</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-7056-0829</orcidid><orcidid>https://orcid.org/0000-0002-2211-8259</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2045-2322 |
ispartof | Scientific reports, 2018-06, Vol.8 (1), p.9821-12, Article 9821 |
issn | 2045-2322 2045-2322 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6026137 |
source | Publicly Available Content Database; Full-Text Journals in Chemistry (Open access); PubMed Central; Springer Nature - nature.com Journals - Fully Open Access |
subjects | 13/51 14/63 38/77 692/420 692/699 Antigens Complement activation Complement component C3 Degeneration Glaucoma Humanities and Social Sciences Immunization Interleukin 1 Mannose multidisciplinary NF-κB protein Nuclei Optic nerve Retina Retinal ganglion cells S100b protein Science Science (multidisciplinary) TLR4 protein Toll-like receptors |
title | S100B immunization triggers NFκB and complement activation in an autoimmune glaucoma model |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T05%3A57%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=S100B%20immunization%20triggers%20NF%CE%BAB%20and%20complement%20activation%20in%20an%20autoimmune%20glaucoma%20model&rft.jtitle=Scientific%20reports&rft.au=Reinehr,%20Sabrina&rft.date=2018-06-29&rft.volume=8&rft.issue=1&rft.spage=9821&rft.epage=12&rft.pages=9821-12&rft.artnum=9821&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-018-28183-6&rft_dat=%3Cproquest_pubme%3E2061817583%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3896-ad7f619e9346cdcd23a62372351e59070f0bf8f909e3d738a61d97a4bc4400b23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2061817583&rft_id=info:pmid/29959432&rfr_iscdi=true |